HKU Scholars Hub: Browsing DSpace

Browsing "Clinical Trials Centre" by Author chan, p

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 10 of 10

	Title	Author(s)	Issue Date
	Combination of bevacizumab and erlotinib in the treatment of patients with advanced hepatocellular carcinoma with sorafenib-refractory disease: results of a pilot phase II study Proceeding/Conference:European Journal of Cancer	Yau, T Wong, H Chan, P Yao, T Cheung, TT Fan, ST Poon, RTP	2012
	Cost-effectiveness analysis of colorectal cancer screening in Hong Kong Proceeding/Conference:Research Postgraduate Symposium, RPS 2011	Wong, KH Lam, CLK Law, WL Poon, JTC Chan, P McGhee, S Fong, DYT Kwong, DLW Tsang, JWH	2011
	Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective Journal:Journal of Evaluation in Clinical Practice	Wong, CKH Lam, CLK Poon, JTC Mcghee, SM Law, WL Kwong, DLW Tsang, J Chan, P	2012
	Efficacy and safety of single agent sunitinib in treating Sorafenib Refractory Advanced Hepatocellular Carcinoma Patients: a prospective, open-label, phase II study Proceeding/Conference:Liver Cancer	Yau, TCC Leung, RCY Wong, HYH Chiu, JWY Chan, P Tang, YF Cheung, TT Pang, RWC Fan, ST Poon, RTP	2013
	Efficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma Proceeding/Conference:Journal of Clinical Oncology	Wong, H Yau, CC Yao, T Tang, V Chan, P Chiu, J Fan, ST Poon, R	2010
	A multicenter phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group study Proceeding/Conference:Journal of Clinical Oncology	Yau, TCC Cheung, FY Lee, F Choo, SP Wong, HYH Toh, HC Leung, AK Chan, P Yau, TK Wong, J Tang, YF Lau, JSM Cheung, TT Fan, ST Poon, RTP	2013
	A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: Implication for patient selection in systemic therapy trials Journal:Cancer	Yau, T Tzy, JY Chan, P Ng, K Sheung, TF Poon, RTP	2008
	The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (hcc) Journal:Oncologist	Wong, H Tang, YF Yao, TJ Chiu, J Leung, R Chan, P Cheung, TT Chan, AC Pang, RW Poon, R Fan, ST Yau, T	2011
	The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization Journal:Cancer	Yau, T Yao, TJ Chan, P Epstein, RJ Ng, KK Chok, KSH Cheung, TT Fan, ST Poon, RTP	2009
	Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease Journal:Investigational New Drugs	Yau, T Wong, H Chan, P Yao, TJ Pang, R Cheung, TT Fan, ST Poon, RT	2012

Showing results 1 to 10 of 10